SigTuple’s AI100 revolutionizes the healthcare sector | Fusion - WeRIndia

In the world of healthcare technology, Tathagato Rai Dastidar stands as a testament to perseverance and persistence.

As the Co-founder and CEO of SigTuple Technologies, he embarked on a remarkable journey after the tragic loss of his father to misdiagnosis of acute myeloid leukaemia almost two decades ago.

Driven by a determination to make a difference in the healthcare sector, he left his comfortable job and delved into the entrepreneurial realm.

Despite lacking a medical sciences background, Tathagato saw immense potential in leveraging artificial intelligence (AI) to unlock the untapped value of healthcare data.

In 2015, SigTuple was born with a vision to revolutionize the manual review of visual medical data using AI.

Tathagato’s ultimate goal was to streamline the work of medical practitioners and reduce human errors.

Besides, it intends to facilitate telemedicine for wider access to screening tests.

The startup initially focused on a microscopic review of blood samples, later expanding to urine and semen microscopy and retinal image analysis.

Along the way, their efforts bore fruit, with the team publishing multiple research papers and securing 11 patents.

After rigorous clinical validations, SigTuple achieved international regulatory clearance for two of its products.

Operating in the pathology and ophthalmology domains, SigTuple offers innovative solutions in the form of an automated digital microscope and an AI platform.

The AI100, a smart digital microscope powered by AI, transforms physical samples into digital images.

Subsequently, the AI platform analyzes these images and generates a report for pathologist review.

By early 2019, AI100 was ready for beta testing, providing valuable insights through customer feedback to refine the product.

However, the COVID-19 pandemic interrupted their commercialization plans, forcing a delay until late 2021, when the second wave subsided.

Nevertheless, AI100 proved to be a game-changer, enabling digital microscopy over the internet and eliminating the need for pathologists to be physically present in the lab.

With AI’s efficiency, pathologists could now handle a significantly higher number of samples in a day, enhancing overall productivity.

Tathagato Rai Dastidar’s journey exemplifies the power of determination and the potential of AI in revolutionizing healthcare.

SigTuple’s innovative solutions are ushering in a new era of medical diagnostics, simplifying the lives of doctors and increasing accessibility to healthcare services.

As they continue to make strides in the pathology and ophthalmology sectors, SigTuple’s impact on the healthcare industry promises to be profound and far-reaching.

Image Credit: Sigtuple Website Screenshot

Image Reference: https://sigtuple.com/